http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MY-126476-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D243-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D243-10
filingDate 1999-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b311341cd93718c440c2785629957b2a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ebdab363d8614c1ac498781fe21fa47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aebf6bd2c18012e0640ef2ef404d3444
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d02a56d50cd8f97274c58b2a50ded0aa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab5cb5022bae286d984769ddeb7617f9
publicationDate 2006-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MY-126476-A
titleOfInvention 2-methyl-thieno-benzodiazepine formulation
abstract THE INVENTION PROVIDES A PHARMACEUTICALLY ACCEPTABLE OLEAGINOUS OR CHOLESTEROL MICROSPHERE FORMULATION OF OLANZAPINE OR OLANZAPINE PAMOATE OR SOLVATES THEREOF. THE INVENTION FURTHUR PROVIDES NOVEL OLANZAPINE PAMOATE SALTS OR SALTS SOLVATES THEREOF.
priorityDate 1998-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421308988
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135566032
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5997
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449863409
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69224317
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507953
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398745
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507378

Total number of triples: 36.